Laparoscopic rectal cancer surgery with and without neoadjuvant chemo-irradiation: a comparative study

Area of Science:

• Oncology
• Surgical Oncology
• Minimally Invasive Surgery

Background:

• Neoadjuvant chemo-irradiation is used for rectal cancer treatment.
• Evaluating the impact of neoadjuvant therapy on surgical outcomes is crucial.

Purpose of the Study:

• To compare perioperative and short-term outcomes of laparoscopic rectal cancer surgery in patients who received neoadjuvant chemo-irradiation versus those who did not.
• To assess the safety and feasibility of minimally invasive surgery for rectal cancer following neoadjuvant therapy.

Main Methods:

• Comparative cohort study.
• Inclusion of patients undergoing elective laparoscopic rectal cancer surgery.
• Comparison between a study group (neoadjuvant chemo-irradiation) and a control group (no neoadjuvant therapy).

Main Results:

• No significant differences in blood loss, conversion rates, postoperative morbidity, hospital stay, or sphincter preservation.
• Median operating time was slightly longer in the neoadjuvant group (155 vs. 135 minutes).
• Overall 5-year survival rates were similar between the groups.

Conclusions:

• Laparoscopic rectal cancer surgery following neoadjuvant chemo-irradiation is safe and does not increase morbidity.
• Patients undergoing neoadjuvant therapy should not be discouraged from opting for minimally invasive laparoscopic surgery.